Recombinant adenovirus-p21 attenuates proliferative responses associated with excessive scarring

Wound Repair and Regeneration

Volumn 13, Issue 5, 2005, Pages 480-490

  Gu, Danling ^a   Atencio, Isabella ^a   Kang, David W ^a   Looper, David ^a   Ahmed, C M I ^a   Levy, Alina ^a   Maneval, Dan ^a   Zepeda, Monica L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 1; KI 67 ANTIGEN; PLATELET DERIVED GROWTH FACTOR B; POLYVINYL ALCOHOL; PROCOLLAGEN;

ADENOVIRUS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; FIBROBLAST; GRANULATION TISSUE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR; STAINING;

ADENOVIRIDAE; ADULT; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CICATRIX; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FIBROBLASTS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MODELS, ANIMAL; PROCOLLAGEN; RATS; SKIN; WOUND HEALING;

EID: 28944450145     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2005.00068.x     Document Type: Article

References (53)

1. Hunt TK. Disorders of wound healing. World J Surg 1980;4:271-7.
2. Nicolai JP, Bos MY, Bronkhorst FB, Smale CE. A protocol for the treatment of hypertrophic scars and keloids. Aesthet Plast Surg 1987;11:29-32.
3. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Teot L, Wood FM, Ziegler UE. International clinical recommendations on scar management. Plast Reconstr Surg 2002;110:560-71.
4. Clark RAF. Wound repair: overview and general considerations. In: Clark RAF, editor. The molecular and cellular biology of wound repair. New York: Plenum Press, 1988: 3-35.
5. Tredget EE. Pathophysiology and treatment of fibroproliferative disorders following thermal injury. Ann NY Acad Sci 1999;888:165-82.
6. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 1989;84:827-37.
7. Tsao SS, Dover JS, Arndt KA, Kaminer MS. Scar management: keloid, hypertrophic, atrophic, and acne scars. Semin Cutan Med Surg 2002;21:46-75.
8. Nemeth AJ. Keloids and hypertrophic scars. J Dermatol Surg Oncol 1993;19:738-46.
9. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
10. el-Deiry WS, Harper JW, O'Conner PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
11. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16.
12. Gartel AL, Sefas MS, Tyner AL. p21 - negative regulator of the cell cycle. Proc Soc Exp Biol Med 1996;213:138-49.
13. Joshi US, Chen YQ, Kalemkerian GP, Adil MR, Kraut M, Sarkar FH. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. Cancer Gene Ther 1998;5:183-91.
14. Erhardt JA, Pittman RN. p21WAF1 induces permanent growth arrest and enhances differentiation, but does not alter apoptosis in PC12 cells. Oncogene 1998;16:443-51.
15. Mobley SR, Liu TJ, Hudson JM, Clayman GL. In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy. Arch Otolaryngol Head Neck Surg 1998;124:88-92.
16. Perkins TW, Faha B, Ni M, Kiland JA, Poulsen GL, Antelman D, Atencio I, Shinoda J, Sinha D, Brumback L, Maneval D, Kaufman PL, Nickells RW. Adenovirus-mediated gene therapy using human p21WAF-1/Cip-1 to prevent wound healing in a rabbit model of glaucoma filtration surgery. Arch Ophthalmol 2002;120: 941-9.
17. Wills KN, Maneval DC, Menzel P, Harris MP, Sutjipto S, Vaillancourt MT, Huang WM, Johnson DE, Anderson SC, Wen SF, Bockstein R, Shepard HM, Gregory RJ. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther 1994;5:1079-88.
18. Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996;70:4805-10.
19. Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Horn MT, Huyghe BG, Liu X, Nunnally MH, Sugarman BJ, Sutjipto S. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 1997;8:453-65.
20. Zhang G, Gurtu V, Kain SR, Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 1997;23:525-31.
21. Brand K, Klocke R, Possling A, Paul D, Strauss M. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther 1999;6:1054-63.
22. Parsons M, Kessler E, Laurent GJ, Brown RA, Bishop JE. Mechanical load enhances procollagen processing in dermal fibroblasts by regulating levels of procollagen C-proteinase. Exp Cell Res 1999;252:319-31.
23. Lambert CA, Colige AC, Lapiere CM, Nusgens BV. Coordinated regulation of procollagens I and III and their post-translational enzymes by dissipation of mechanical tension in human dermal fibroblasts. Eur J Cell Biol 2001;80:479-85.
24. Yang GP, Lim IJ, Phan TT, Lorenz HP, Longaker MT. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Rep Reg 2003;11:411-8.
25. Haynes JH, Johnson DE, Mast BA, Diegelmann RF, Salzberg DA, Cohen IK, Krummel TM. Platelet-derived growth factor induces fetal wound fibrosis. J Pediatr Surg 1994;29:1405-8.
26. Dang CM, Beanes SR, Soo C, Ting K, Benhaim P, Hedrick MH, Lorenz HP. Decreased expression of fibroblast and keratinocyte growth factor isoforms and receptors during scarless repair. Plast Reconstr Surg 2003;111:1969-79.
27. Buckley A, Davidson JM, Kamerath CD, Wolt TB, Woodward SC. Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci USA 1985;82:7340-4.
28. Liechty KW, Nesbit M, Herlyn M, Radu A, Adzick NS, Crombleholme TM. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 1999;113:375-83.
29. Barnard NJ, Hall PA, Lemoine NR, Kadar N. Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987;152:287-95.
30. Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene 1998;16:2141-50.
31. Crary GS, Albrecht JH. Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology 1998;28:738-43.
32. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 1998;82:396-403.
33. Zhu X, Hu C, Zhang Y, Li L, Wang Z. Expression of cyclin-dependent kinase inhibitors, p21cip1 and p27kip1, during wound healing in rats. Wound Rep Reg 2001;9:205-12.
34. Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, Longaker MT, Zhang X, Ting K. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 1999;87:209-16.
35. Teramoto S, Johnson LG, Huang W, Leigh MW, Boucher RC. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum Gene Ther 1995;6:1045-53.
36. Wersto RP, Rosenthal ER, Seth PK, Eissa NT, Donahue RE. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J Virol 1998;72:9491-502.
37. Saika S, Ooshima A, Yamanaka O, Kimura M, Okada Y, Tonoe O, Tanaka S, Ohnishi Y. In vitro effects of doxorubicin and mitomycin C on human Tenon's capsule fibroblasts. Ophthalmic Res 1997;29:91-102.
38. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996;98:827-33.
39. Kim SJ, Won YH. The effect of glycolic acid on cultured human skin fibroblasts: cell proliferative effect and increased collagen synthesis. J Dermatol 1998;25:85-9.
40. Telasky C, Tredget EE, Shen Q, Khorramizadeh MR, Iwashina T, Scott PG, Ghahary A. IFN-alpha2b suppresses the fibrogenic effects of insulin-like growth factor-1 in dermal fibroblasts. J Interferon Cytokine Res 1998;18:571-7.
41. Naruse S, Yamada J, Hamuro J, Kobayashi T, Mori K, Kinoshita S. APC0576 decreases production of pro-inflammatory chemokine and extracellular matrix by human Tenon's capsule fibroblasts. Exp Eye Res 2004;79:223-30.
42. Furth JJ, Allen RG, Tresini M, Keogh B, Cristofalo VJ. Abundance of alpha 1(I) and alpha 1(III) procollagen and p21 mRNAs in fibroblasts cultured from fetal and postnatal dermis. Mech Ageing Dev 1997;97:131-42.
43. Dumas M, Chaudagne C, Bonte F, Meybeck A. In vitro biosynthesis of type I and III collagens by human dermal fibroblasts from donors of increasing age. Mech Ageing Dev 1994;73:179-87.
44. Pierce GF, Mustoe TA, Senior RM, Reed J, Griffin GL, Thomason A, Deuel TF. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1988;167:974-87.
45. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem 1991;45:319-26.
46. Doukas J, Chandler LA, Gonzalez AM, Gu D, Hoganson DK, Ma C, Nguyen T, Printz MA, Nesbit M, Herlyn M, Crombleholme TM, Aukerman SL, Sosnowski BA, Pierce GF. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther 2001;12:783-98.
47. Peterson TC, Isbrucker RA. Fibroproliferation in liver disease: role of monocyte factors. Hepatology 1992;15:191-7.
48. Nielsen LL. NK cells mediate the anti-tumor effects of E1-deleted, type 5 adenovirus in a human tumor xenograft model. Oncol Rep 2000;7:151-5.
49. Kajiwara K, Byrnes AP, Charlton HM, Wood MJ, Wood KJ. Immune responses to adenoviral vectors during gene transfer in the brain. Hum Gene Ther 1997;8:253-65.
50. St. George JA, Pennington SE, Kaplan JM, Peterson PA, Kleine LJ, Smith AE, Wadsworth SC. Biological response of nonhuman primates to long-term repeated ling exposure to Ad2/CFTR-2. Gene Ther 1996;3:103-16.
51. Brody SL, Metzger M, Danel C, Rosenfeld MA, Crystal RG. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther 1994;5: 821-36.
52. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
53. Khavari PA, Rollman O, Vahlquist A. Cutaneous gene transfer for skin and systemic diseases. J Intern Med 2002; 252:1-10.